北京大学分子医学研究所博士生导师简介：肖瑞平

　　47. Yang, D., Zhu, W.Z., Xiao, B., Brochet, D., Chen, W., Lakatta, E.G.,, Xiao, R.P., Cheng, H. Ca2+/Calmodulin kinase II -dependent phosphorylation of ryanodine receptors suppresses spontaneous Ca2+ release in cardiac myocytes, Circ Res. 2007, 100:399-40.

　　46. Vinogradova, T.M., Lyashkov, A.E., Zhu, W., Ruknudin, A.M., Sirenko, S., Yang, D., Deo, S., Barlow, M., Johnson, S., Caffrey, J.L., Zhou, Y.Y., Xiao, R.P., Cheng, H., Stern, M.D., Maltsev, V.A. and Lakatta, E.G..: High basal protein kinase A-dependent phosphorylation drives rhythmic internal Ca2+ store oscillations and spontaneous beating of cardiac pacemaker cells. Circ. Res. 98:505-514, 2006.

　　45. Yang, Y., Zhu, W.Z., Joiner, M.L., Zhang, R., Oddis, C.V., Hou, Y., Yang, J., Price, E.E., Gleaves, L., Eren, M., Ni, G., Vaughan, D.E., Xiao, R.P., Anderson, M.E. Calmodulin Kinase II inhibition protects against myocardial apoptosis in vivo by phospholamban-dependent and –independent mechanisms. Am J Physiol Heart Circ Physiol. 2006,291:H3065-75.

　　44. Beigi, F., Bertucci, C., Zhu, W., Chakir, K., Wainer, I.W., Xiao, R.P., Abernethy, D.R. Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol. Chirality. 2006, 18:822-7.

　　43. Xiao, R.P., Zhu, W.Z., Zheng, M., Cao, C.M., Zhang, Y.Y., Lakatta, E.G., Han ,Q,D.: Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci. 27: 330-337, 2006 (Invited review).

　　42. Zhu, W., Zeng, X., Zheng M, Xiao, R.P.: The enigma of cardiac beta2-adrenergic Gi signaling in the heart: the good, the bad, and the ugly. Circ. Res. 97: 507-509, 2005 (Commentary).

　　41. Zheng, M., Zhu, W., Han, Q., Xiao, R.P.: Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling. Pharmacol. Ther. 108: 257-68, 2005 (Invited Review).

　　40. Zhu, W.Z., Yang, D., Zhang, S.J., Chakir, K., Cheng, H., Lavoie, C., Mercier, J.F., Bouvier, M., Hébert, T.E., Lakatta, E.G., Xiao, R.P.: Dimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. Circ. Res. 97: 244-251, 2005.